Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Research Notes

Open Access

DSCR9 gene simultaneous expression in placental, testicular and renal tissues from baboon (papio hamadryas)

  • Irám Pablo Rodriguez-Sanchez1, 2,
  • María Lourdes Garza-Rodríguez2,
  • María Elizabeth Tejero3, 4,
  • Shelley A Cole5,
  • Anthony G Comuzzie3 and
  • Hugo Alberto Barrera-Saldaña1, 2Email author
BMC Research Notes20125:298

https://doi.org/10.1186/1756-0500-5-298

Received: 21 January 2012

Accepted: 15 June 2012

Published: 15 June 2012

Abstract

Background

In 2002 Takamatsu and co-workers described the human DSCR9 gene and observed that it was transcriptionally active in human testicular tissue, but no protein was identified as a product of this transcript. Similar results were obtained in chimpanzee tissue. This gene has not been detected in species other than primates, suggesting that DSCR9 is exclusively found in these mammals.

Results

We report evidence of DSCR9 expression in placenta, testis and kidney of baboon (Papio hamadryas). We used primers specific for DSCR9 to amplify transcripts through reverse transcription (RT) coupled to polymerase chain reaction (PCR). Furthermore, PCR was used to amplify the complete DSCR9 gene from genomic DNA from three baboons. We amplified and sequenced five overlapping segments that were assembled into the 3284 bp baboon DSCR9 gene, including the putative promoter and the entire transcriptional unit (5'-UTR, CDS and 3'-UTR).

Conclusions

The baboon DSCR9 gene is highly similar to the human counterpart. The isolated transcripts from baboon tissues (placenta, testis and kidney) of three different baboons correspond to the human orthologous gene.

Keywords

DSCRPrimateGene expression

Background

Down syndrome (DS) or trisomy 21 is the most common chromosome disorder affecting newborns and the most frequent and recognized cause of mental retardation in Homo sapiens (Hosa)[1]. The incidence of this syndrome is about 1 in 700 newborns [2]. Chromosome 21 is the smallest of human autosomal chromosomes, and an extra copy or additional segment of this chromosome causes DS [3]. The chromosomal region responsible for this pathology has been described [4] and named Down Syndrome Critical Region (DSCR)[5, 6]. By comparing the genomic DSCR sequence in humans with that of other species, it was shown that it is highly conserved in great apes[6] and similar trisomies have been described in these non human primates [7, 8]. In humans, ten potential genes have been identified in the DSCR, two of which (DSCR9 and DSCR10) are exclusive of primates [9]. In man, DSCR9 gene transcription, but not proteins, were evidenced in testicle; this was also demonstrated in chimpanzee [9]. The aim of this study was to identify the chromosome segment from which the DSCR9 gene´s transcripts originated.

We amplified five segments from the baboon genome using primers designed to render overlapping amplicons. Using this strategy we were able to assemble the complete DSCR9 gene of the species. The isolated genomic segment includes the putative promoter and the complete transcriptional unit. Using reverse transcription (RT) coupled to polymerase chain reaction (PCR), we have gathered evidenced of the expression of the DSCR9 gene in baboon’s placenta, testicles, and kidney, an of its lack of detectable expression in heart, omental fat, skeletal muscle, pancreas, mononuclear cells, liver, and hypothalamus. The identified transcripts of these tissues in three different individual were identical and correspond to the isolated DSCR9 baboon gene.

Methods

Animal specimens

Animal procedures were performed according to ethical guidelines and reviewed by the Institutional Animal Care and Use Committee of the Texas Biomedical Research Institute (TBRI). Animals were maintained at the Southwest National Primate Research Center in San Antonio, Texas at TBRI. All the animals shared the same diet and environmental conditions before and during pregnancy. All baboons are gang-housed and fed ad libitum on a standard low-fat chow diet (Harlan Tecklad 15% Monkey Diet, 8715).

Biological samples

Different tissues from tree male baboons (testis, kidney, heart, omental fat, skeletal muscle, pancreas, mononuclear cells, liver, and hypothalamus) and from tree female baboons (ovary and placenta) were collected in programmed necropsies, under fasting conditions. Placental tissues were collected by caesarean section at the time of birth [at the term period of gestation for this species (136 to 139 days)]. All tissues were stored in liquid nitrogen immediately after collection until needed.

Nucleic acid isolation from placental tissue

Genomic DNA and total RNA were isolated from each tissue using TRIZOL reagent; procedures were performed according to the manufacturer's instructions (Invitrogen, Carlsbad, CA). RNA samples were treated with DNase I (Invitrogen) for 10 min at 37 °C to remove traces of genomic DNA, genomic DNA was treated with RNase I (Invitrogen) for 30 min at 37 °C to remove traces of RNA. RNA and DNA quality and integrity were assessed by standard spectrophotometric and electrophoretic methods, respectively.

Reverse transcription

RT reactions were carried-out with 1 μg of total RNA using random primers and a High-capacity cDNA Reverse Transcription kit, following manufacturer’s instructions (Applied Biosystems, Foster City, CA).

Primer design

To amplify baboon DSCR9 gene and transcript, primers were designed based on highly conserved primate DSCR9 sequences previously reported [great apes and old world monkeys (OWMs)] and using the online primer-3 tool [10]. Primers (see Table 1) were designed to amplify overlapping target template sequences in order to isolate the complete DSCR9 gene (in concordance with human gene structure).
Table 1

Primers and PCR conditions

Oligo name

Oligo sequence

Orientation

Primer set

Substrate to PCR

Initial denatur alization

Amplification program

Cycles

Final elongation

Amplicon size

Denaturalization

Alignment

Elongation

OLIGO-rnaF

CTTGGCGCTAAGCTGCCGC

Forware

AMPLICON -mRNA

mRNA

94°/3.5 min

94°/30 seg

60°/45 seg

72°/30 seg

42

72°/15 min

726 pb

OLIGO-rnaR

CCTGCTCTGGAGTCTTGGTG

Reverse

         

OLIGO-gene1F

AGCTGGCACTCCCCAGAAT

Forware

OLIGO-gene1

gDNA

94°/5 min

94°/1 min

60°/45 seg

72°/1 min

35

72°/10 min

946 pb

OLIGO-gene1R

GGCTGAGGCACAGAGAAACT

Reverse

         

OLIGO-gene2F

CTCCCTACCAAAGTGGCTAG

Forware

OLIGO-gene2

gDNA

94°/5 min

94°/1 min

60°/45 seg

72°/35 seg

30

72°/10 min

769 pb

OLIGO-gene2R

TGTGGAAAGTTGGGGTTTTC

Reverse

         

OLIGO-gene3F

GAAAACCCCAACTTTCCACA

Forware

OLIGO-gene3

gDNA

94°/5 min

94°/1 min

60°/45 seg

72°/30 seg

30

72°/10 min

723 pb

OLIGO-gene3R

CCAGGCGAGCAGTCTGTAAC

Reverse

         

OLIGO-gene4F

CCTCTCCTGCAACCAATCAG

Forware

OLIGO-gene4

gDNA

94°/5 min

94°/1 min

60°/45 seg

72°/45 seg

30

72°/10 min

807 pb

OLIGO-gene4R

CCCGAATATCCTGGGCTCT

Reverse

         

OLIGO-gene5F

CCGGAAGAGCCCAGGATA

Forware

OLIGO-gene5

 

94°/5 min

94°/1 min

60°/45 seg

72°/1 min

gDNA

35

72°/10 min

967 pb

OLIGO-gene5R

CCGTTTTGGCAGGAATACAT

Reverse

          

PCR amplification

To amplify DSCR9 gene from genomic DNA five primer sets were used in separate PCR reactions (Table 1). Each PCR reaction was performed in 50 μl reaction containing 10 pM of each primer, 200 ng of genomic DNA and 2X PCR master mix (Qiagen, Valencia, CA). To amplify DSCR9-related transcript, a primers set (see Table 1) was used with 10 pM of each primer and 5 μl of RT reaction from each tissue. PCR amplification programs are described in Table 1. Universal 18 s ribosomal gene primers were used in RT-PCR as positive control. (Ambion, Austin, TX). PCR amplifications were confirmed by electrophoresis in agarose gel (1%) run in TAE X1 buffer, stained with etidium bromide and visualized under UV light.

Molecular cloning and sequencing

PCR products were cloned using the TOPOXL cloning system with the pCR-XL-TOPO 3.5 kb vector (Invitrogen). Ligation reactions were transformed into electrocompetent Top 10 Escherichia coli bacterium according to the manufacturer’s instructions (Invitrogen). Cloning products were sequenced in an ABI PRISM 3100 Genetic Analyzer (Applied Biosystems) using universal M13 primers, and Big Dye terminator reagent (Applied Biosystems). Novel sequence has been deposited in the GenBank database (Accession number: JF775469).

Sequence analysis

Electropherograms were analyzed using GeneStudio Pro software (GeneStudio, Inc., Suwanee, GA). Procedures were carried out in three clones for each amplicon to exclude artifacts. DNA sequences from DSCR9-related transcripts were used to determine the amino acid sequence using the Transeq online program [11] and were subsequently aligned using the ClustalW program [12] and Vista tools [13]. The alignments were performed using peptide sequences extracted from GenBank [14] by homology search.

Results

Baboon DCSR9 gene isolation

Baboon genomic DSCR9 gene was isolated by PCR in five overlapping segments (see Figure 1), which were cloned and sequenced. The assembled sequenced gene was submitted with the BLAST tool of NCBI to the GenBank and match was confirmed with the human DSCR9 gene (data not shown).
Figure 1

Strategy to isolate overlapping segments of Papio hamadryas DSCR9 gene. A: Anatomy of the Paha DSCR9 genomic gene. B: Assembly of Paha DSCR9 gene; Primer positions correspond to forward primer and to reverse primers; illustrated amplicons cover the complete DSCR9 amplified gene (blue lines correspond to amplicons generated from genomic DNA and pink line correspond to DSCR9-related transcript).

DSCR9 gene of papio hamadryas

The assembled baboon DSCR9 gene lacks a TATA box, conventional Kozak sequence [15, 16], introns, and polyadenylation signal. The baboon DSCR9 gene has a structure similar to its human counterpart (Figure 2) but with substantial size difference mainly. For example, while the length of gene, putative promoter, messenger RNA (mRNA), 5´-untranslated region (UTR), coding DNA sequence (CDS) and 3´-UTR for baboon are: 3284, 1861, 1423, 754, 505 and 164 bp (base pair), those of the human are: 3385, 1975, 1410, 767, 450 and 193 bp.
Figure 2

DSCR9 transcripts. Nucleotide sequences alignment of baboon and human DSCR9 genes. Both UTRs (5´and 3´) are in grey lower case and the region corresponding to the CDS is in black capital letter. Primers are highlighted in red lower case and the stop codon is in red capital letter

DSCR9 gene putative promoter analysis

Based on the structure of the DSCR9 human gene, we performed the amplification of an upstream region of the transcriptional unit, which we proposed as the putative promoter. The obtained sequence was compared with its counterpart in Hosa[9], which was 93% identical (see Figure 3). Additional experiments of transcriptional activity are required to validate the promoter activity of this DNA segment.
Figure 3

Comparison of DSCR9 promoter of human vs baboon. A: sequence alignment. B: Comparison of the two promoters using the Vista Tool program [13].

Papio hamadryas DSCR9 transcript detection

In order to determine DSCR9 gene expression in baboon, total RNA was extracted from testis, kidney, cardiac, omental fat, skeletal muscle, pancreas, mononuclear cells, liver, and hypothalamus, placenta and ovary tissues. Total RNA was used for cDNA synthesis by RT. For DSCR9 transcript isolation an oligo set was designed consisting of a forward consensus primer (DSCR9-rnaF) hybridizing at 148 bases upstream from the translation initiation codon (AUG) and a reverse primer (DSCR9-rnaR) annealing 36 bases after the termination codon (UGA) (positions according to Hosa DSCR9 mRNA [9]). We detected an amplified product in three different tissues: placental, testis and kidney. A single band was amplified in each case. The size of the amplified product (Paha: 726 b) was larger than expected, according to the human sequence (Hosa: 673 b). We used amplification of ribosomal RNA 18 s as positive control for each tissue. Negative and positive controls gave the expected results. Expression in heart, omental fat, skeletal muscle, pancreas, mononuclear cells, liver, and hypothalamus was discarded, at least to the sensitivity levels of the used RT-PCR techniques.

The baboon DSCR9 gene sequence, which is also that of its mRNA since it is an intronless gene, was compared with its Hosa counterpart and found to be 90% identical. This value decreases to 89% if just the CDS of both genes are compared. A single thymine nucleotide insertion (underlined in black) results in a premature stop codon (showed in a box), which is predicted to decrease the polypeptide length to 50 aa (see Figure 2). Consequently, from this point on both conceptually translated proteins lose their similarity.

Discussion

The expression of DSCR9 gene evidenced in baboon's testicular, kidney and placental tissues coincides with previous reports of expression in humans in the former tissue, but differs in that of the later two organs. The sequences of DSCR9 gene transcripts in all baboon tissues were identical and without evidence of alternative splicing, unlike those reported for human in which eight different mRNA species have been described (see Table 2). Currently, the predicted DSCR9 protein has not been detected and thus the function of this gene remains unknown. It is hypothesized that allelic variants of the DSCR9 gene may influence the accumulation of connective tissue of the iris resulting in the phenotype of a different eye color [10]. Probably the DSCR9 gene is expressed constitutively in the iris and/or acts in a regulatory manner through RNA interference and/or modifies the expression of other genes in the tissue that is associated with a specific phenotype.
Table 2

Reported transcripts from nucleotide databases

Species

Tissue

Testis

Unknown

Liver

Placenta

Kidney

Skeletal muscle

Spleen

Brain

Caudate nucleus

Unknown

Homo sapiens

NR_026719*

 

AB212291*

  

AB212287*

AB212 289*

AB212 290*

AK313 458*

 
       

AB212 288*

AB212 286*

  

Papio anubis

   

SRR001694**

      

Macaca fascicularis

AB168984*

   

DC640452***

     
 

CJ490857*

         

Callithrix jacchus

 

SRR000079**

       

SRR000079**

* = Core subset of nucleotide sequence records, ** = SRA, *** = EST of GenBank at the NCBI.

Conclusion

In our study we found a homologous region to the human DSCR9 gene in the Papio hamadryas genome. We provide evidence of the expression of DSCR9 gene in baboon's testicular, kidney and placental tissues and of lack of expression in heart, omental fat, skeletal muscle, pancreas, mononuclear cells, liver, and hypothalamus. The segments that compose the transcript unit were assigned based on the strategy described previously by Takamatsu, et al. [9]. Experiments like RNA-RACE are necessary to found 5'-CAP element and designate the length of the 5'-UTR (size in nucleotides). We proposed our gene elements´ nomenclature according to the gene annotation made by Takamatsu et al. [9]. According to our findings, the predicted baboon 5´-UTR has a second ATG sequence that initiates a putative ORF of only three amino acids in length. Then, we agreed with the start codon proposed by Takamatsu et al. [9]. The function of this gene remains unknown, but at least in baboon seems to be dispensable since its corresponding mRNA has a single nucleotide insertion that results in a premature termination of protein. Further studies on the function of this protein in human and other primates are required to understand its role and possible association with the DS phenotype.

Abbreviations

DS: 

Down Syndrome

DSCR: 

Down Syndrome Critical Region

DSCR9: 

Down Syndrome Critical Region 9

Paha: 

Papio hamadryas

Hosa: 

Homo sapiens

b: 

base

bp: 

base pairs

PCR: 

Polymerase Chain Reaction

RT: 

Reverse Transcription

EST: 

expressed sequence tag

SRA: 

Sequence Read Archive

mRNA: 

messenger RNA

CDS: 

coding DNA sequence

UTR: 

untranslated region.

Declarations

Acknowledgements

The present work was supported by grants from the Mexican Council of Sciences and Technology, CONACyT (U43987-Q), UANL's PAICyT (SA972-04), Research Facilities Improvement Program (C06RR014578, C06 RR13556, C06 RR015456 and C06 RR017515) and from the NIH (PO1 HL028972 and P51 RR013986). IPRS enjoyed an SNI assistantship and a visiting student fellowship from the Department of Genetics at TBRI. The authors gratefully acknowledge the critical reading of the manuscript by Sergio Lozano.

Authors’ Affiliations

(1)
Vitaxentrum. Blvd. Puerta del Sol 1005, Colinas de San Jerónimo
(2)
Facultad de Medicina, Departamento de Bioquímica y Medicina Molecular, Universidad Autonoma de Nuevo León, Av.
(3)
Auxology and Metabolism Working Group, and Texas Biomedical Research Institute
(4)
Instituto Nacional de Medicina GenómicaPeriférico sur 4124. Torre Zafiro II Col Ex Rancho de Anzaldo, México
(5)
Department of Genetics, Texas Biomedical Research Institute

References

  1. Patterson D: Genetic mechanisms involved in the phenotype of Down syndrome. Ment Retard Dev Disabil Res Rev. 2007, 13: 199-206. 10.1002/mrdd.20162.PubMedView ArticleGoogle Scholar
  2. Megarbane A, Ravel A, Mircher C, Sturtz F, Grattau Y, Rethore MO, Delabar JM, Mobley WC: The 50th anniversary of the discovery of trisomy 21: the past, present, and future of research and treatment of Down syndrome. Genet Med. 2009, 11: 611-616. 10.1097/GIM.0b013e3181b2e34c.PubMedView ArticleGoogle Scholar
  3. Hattori M, Fujiyama A, Sakaki Y: The DNA sequence of human chromosome 21. Tanpakushitsu Kakusan Koso. 2001, 46: 2254-2261.PubMedGoogle Scholar
  4. McCormick MK, Schinzel A, Petersen MB, Stetten G, Driscoll DJ, Cantu ES, Tranebjaerg L, Mikkelsen M, Watkins PC, Antonarakis SE: Molecular genetic approach to the characterization of the "Down syndrome region" of chromosome 21. Genomics. 1989, 5: 325-331. 10.1016/0888-7543(89)90065-7.PubMedView ArticleGoogle Scholar
  5. Toyoda A, Noguchi H, Taylor TD, Ito T, Pletcher MT, Sakaki Y, Reeves RH, Hattori M: Comparative genomic sequence analysis of the human chromosome 21 Down syndrome critical region. Genome Res. 2002, 12: 1323-1332. 10.1101/gr.153702.PubMedPubMed CentralView ArticleGoogle Scholar
  6. Luke S, Gandhi S, Verma RS: Conservation of the Down syndrome critical region in humans and great apes. Gene. 1995, 161: 283-285. 10.1016/0378-1119(95)00270-G.PubMedView ArticleGoogle Scholar
  7. Benirschike K, Bogart MH, McClure HM, Nelson-Rees WA: Fluorescence of the trisomic chimpanzee chromosomes. J Med Primatol. 1974, 3: 311-314.PubMedGoogle Scholar
  8. McClure HM, Belden KH, Pieper WA, Jacobson CB: Autosomal trisomy in a chimpanzee: resemblance to Down's syndrome. Science. 1969, 165: 1010-1012. 10.1126/science.165.3897.1010.PubMedView ArticleGoogle Scholar
  9. Takamatsu K, Maekawa K, Togashi T, Choi DK, Suzuki Y, Taylor TD, Toyoda A, Sugano S, Fujiyama A, Hattori M, et al: Identification of two novel primate-specific genes in DSCR. DNA Res. 2002, 9: 89-97. 10.1093/dnares/9.3.89.PubMedView ArticleGoogle Scholar
  10. Liu F, Wollstein A, Hysi PG, Ankra-Badu GA, Spector TD, Park D, Zhu G, Larsson M, Duffy DL, Montgomery GW, et al: Digital quantification of human eye color highlights genetic association of three new loci. PLoS Genet. 2010, 6: e1000934-10.1371/journal.pgen.1000934.PubMedPubMed CentralView ArticleGoogle Scholar
  11. Payton JE, Grieselhuber NR, Chang LW, Murakami M, Geiss GK, Link DC, Nagarajan R, Watson MA, Ley TJ: High throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samples. J Clin Invest. 2009, 119: 1714-1726. 10.1172/JCI38248.PubMedPubMed CentralView ArticleGoogle Scholar
  12. Ahmed TR, Mordan NJ, Gilthorpe MS, Gillam DG: In vitro quantification of changes in human dentine tubule parameters using SEM and digital analysis. J Oral Rehabil. 2005, 32: 589-597. 10.1111/j.1365-2842.2005.01473.x.PubMedView ArticleGoogle Scholar
  13. Arai S, Hara Y, Mimura K, Nagasawa H, Nishijima Y: Analysis of pigmentation in human skin: quantification of ultraviolet ray images by digital image processing. Int J Cosmet Sci. 1989, 11: 103-120. 10.1111/j.1467-2494.1989.tb00500.x.PubMedView ArticleGoogle Scholar
  14. Nolano M, Provitera V, Crisci C, Stancanelli A, Wendelschafer-Crabb G, Kennedy WR, Santoro L: Quantification of myelinated endings and mechanoreceptors in human digital skin. Ann Neurol. 2003, 54: 197-205. 10.1002/ana.10615.PubMedView ArticleGoogle Scholar
  15. Kozak M: An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 1987, 15: 8125-8148. 10.1093/nar/15.20.8125.PubMedPubMed CentralView ArticleGoogle Scholar
  16. Kozak M: Downstream secondary structure facilitates recognition of initiator codons by eukaryotic ribosomes. Proc Natl Acad Sci USA. 1990, 87: 8301-8305. 10.1073/pnas.87.21.8301.PubMedPubMed CentralView ArticleGoogle Scholar

Copyright

© Rodriguez-Sanchez et al.; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement